fenfluramine) oral solution, CIV
Initial U.S. Approval: 1973
FINTEPLA is indicated for the treatment of seizures associated with Dravet syndrome in patients 2 years of age and older
Facts about fenfluramine oral solution
Approval Date: 1973
Proprietary Name: On Request
Active Ingredient(s): fenfluramine oral solution
FDA-approved use: Lennox-Gastaut syndrome, another form of epilepsy
Medicine Approved By: – European Medical Agency (EMA), Food and Drug Administration (FDA),
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)
Access the best support services globally
If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “fenfluramine oral solution” based on the information you provide.
Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.